| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/06/2005 | WO2005000198A2 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/06/2005 | WO2005000197A2 Selective serine/threonine kinase inhibitors |
| 01/06/2005 | WO2005000196A2 Inhibition of egr-1 expression by rpar-ϝ agonista and related compositions and methods |
| 01/06/2005 | WO2005000195A2 A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 01/06/2005 | WO2005000194A2 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same |
| 01/06/2005 | WO2005000193A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 01/06/2005 | WO2004096138A3 [18f]-furanosylpurine derivatives and uses thereof |
| 01/06/2005 | WO2004093800A3 Thyronamine derivatives and analogs and methods of use thereof |
| 01/06/2005 | WO2004082604A3 Phosphoric ester demulsifier composition |
| 01/06/2005 | WO2004071449A3 Lactams as modulators of chemokine receptor activity |
| 01/06/2005 | WO2004071388A3 Medicinal compounds |
| 01/06/2005 | WO2004071385A3 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 01/06/2005 | WO2004071382A3 Substituted heterocycles |
| 01/06/2005 | WO2004071376A3 Oral care composition comprising an antimicrobial agent |
| 01/06/2005 | WO2004069202A3 Antiglucocorticoids for the treatment of postpartum psychosis |
| 01/06/2005 | WO2004066936A3 Method and assembly for liquid nitrogen therapy |
| 01/06/2005 | WO2004064751A3 Nanoparticle based stabilization of ir fluorescent dyes |
| 01/06/2005 | WO2004058167A3 Breast specific protein expressed in cancer and methods of use thereof |
| 01/06/2005 | WO2004054512A3 Therapeutic retroviral vectors for gene therapy |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050005314 Animal model comprising constitutively exprressed anaplastic lymphoma kinase (ALK) gene for use in identifying agents which prevent and treat tumor metastasis; gene expression inhibition; RNA interference; immunotherapy |
| 01/06/2005 | US20050004357 Industrially scalable nucleoside synthesis |
| 01/06/2005 | US20050004232 Acyl sulfonamides as inhibitors of HIV integrase |
| 01/06/2005 | US20050004224 Reducing production of amyloid beta protein; fewer side effects |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004184 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones |
| 01/06/2005 | US20050004179 Improving insulin sensitivity; reducing or inhibiting development of memory impairment |
| 01/06/2005 | US20050004176 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/06/2005 | US20050004148 Human immunodeficiency and hepatitis B infections; high activity, low toxicity |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050004117 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 01/06/2005 | US20050004104 Methods for the protection of memory and cognition |
| 01/06/2005 | US20050004099 Spiroazabicyclic heterocyclic compounds |
| 01/06/2005 | US20050004095 Carbacephem beta-lactam antibiotics |
| 01/06/2005 | US20050004059 Gene amplification and overexpression in cancer |
| 01/06/2005 | US20050004044 Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en-22-one 16-0-(2-0-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1->3)-(2-0-acetyl-alpha-L-arabinopyranoside)] or OSW-1 and its derivatives for cancer therapeutics |
| 01/06/2005 | US20050004022 Cognition activators; neuropathic pain; contacting cells with erythropoietin protein |
| 01/06/2005 | US20050004020 Anchoring compound to surface of target cells; protease inhibitors |
| 01/06/2005 | US20050004006 Using transferrins as tool in reducing concentration of serum glucose, blood pressure, obesity or glycosylated hemoglobins; antidiabetic agents |
| 01/06/2005 | US20050003507 Method for purifying virus |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 01/06/2005 | US20050003405 Using g protein coupled receptors expression as diagnostic/prognostic indicator of cell proliferative disorders; immunotherapy |
| 01/06/2005 | US20050003387 Using tumor necrosis factor-related apoptosis-inducing ligand as a tool to identify modulators of programmed cell death for use in treatment of cell proliferative disorders |
| 01/06/2005 | US20050002983 Drug eluting stents having different symptom reducing agents |
| 01/06/2005 | US20050002954 Peptide-based vaccine for influenza |
| 01/06/2005 | US20050002942 Vitamin receptor binding drug delivery conjugates |
| 01/06/2005 | US20050002929 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/06/2005 | US20050002901 Compositions and methods for treating coronavirus infection and SARS |
| 01/06/2005 | US20050002899 Serum and mitogen free; inducing tumor cells to enter proliferative cycle phase |
| 01/06/2005 | US20050002896 Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture |
| 01/06/2005 | US20050002876 Oral care methods and products |
| 01/06/2005 | CA2530582A1 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 01/06/2005 | CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | CA2529873A1 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | CA2529522A1 Methioninase treatment for p.carinii infection |
| 01/06/2005 | CA2529145A1 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
| 01/06/2005 | CA2529103A1 Use of a recombinant vector encoding il-10 for treating neuropathic pain |
| 01/06/2005 | CA2528723A1 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | CA2528155A1 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 01/06/2005 | CA2528146A1 An improved method and apparatus for dosing single and multi-agent therapy |
| 01/06/2005 | CA2527284A1 Methods and compositions for modulating serum cortisol levels |
| 01/06/2005 | CA2525987A1 Methods of treating hyperproliferative cell disorders |
| 01/06/2005 | CA2525589A1 Pancreatic cancer treatment |
| 01/05/2005 | EP1492890A2 Large scale methods of producing adenovirus and adenovirus seed stocks |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | EP1150648A4 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates |
| 01/05/2005 | EP1109537B1 Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate |
| 01/05/2005 | EP1006110B8 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 01/05/2005 | DE10297328T5 Verfahren und Vorrichtung zur verbesserten Steifigkeit in der Verbindungsanordnung eines flexiblen Arms Method and apparatus for improved rigidity in the connection arrangement of a flexible arm |
| 01/05/2005 | CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV |
| 01/05/2005 | CN1561217A Estrogen/gestagen combination preparation and application thereof |
| 01/05/2005 | CN1561208A Methods to mobilize progenitor/stem cells |
| 01/05/2005 | CN1561200A Flashmelt oral dosage formulation |
| 01/05/2005 | CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1182831C Synergistic antibacterial combination |
| 12/30/2004 | US20040268442 Transforming tobacco cell line containing sequences encoding antigens (such as hemagglutinin/neuraminidase protein from Newcastle Disease Virus), culturing, washing, suspending in lysis buffer, disrupting cells, then separating debris; vaccines |
| 12/30/2004 | US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms |
| 12/30/2004 | US20040266989 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/30/2004 | US20040266878 in polymorphic Form A free of other polymorphic forms, used as an antiallergen to treat, e.g., bronchial asthma |
| 12/30/2004 | US20040266818 Histone deacetylase inhibitors; antiproliferative agents; autoimmune, allergic and inflammatory diseases; central nervous system disorders; potency, bioavailability |
| 12/30/2004 | US20040266769 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 12/30/2004 | US20040266759 Possess antithrombotic and anticoagulant properties; example compound: 1-(5-Chlorobenzo[b]furan-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine |
| 12/30/2004 | US20040266745 Estrogen-gestagen combination preparations and uses thereof |
| 12/30/2004 | US20040266743 more than about 20% by weight of the aldosterone receptor antagonist is released at about four hours after initiation of the test |
| 12/30/2004 | US20040266713 Using nucleic acids; antitumor agents |
| 12/30/2004 | US20040266702 Topical treatment or prevention of ocular infections |
| 12/30/2004 | US20040266683 Prevention and treatment of cardiac arrhythmias |
| 12/30/2004 | US20040266682 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits |
| 12/30/2004 | US20040266672 Antiinflammatory agents; anticoagulants; viricides |
| 12/30/2004 | US20040266025 Screening and treatment methods for prevention of preterm delivery |
| 12/30/2004 | US20040265912 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors |
| 12/30/2004 | US20040265790 Methods and compositions for modulating T lymphocytes |
| 12/30/2004 | US20040265400 Compositions for enhancing sexual responsiveness |
| 12/30/2004 | US20040265396 comprises zinc oxide, calcium channel blocker (3,5-pyridinedicarboxylic acid or nifedipine), and fat-soluble vitamins (vitamins A, D, E, K) admixed with antibacterial and antifungal agents; administered orally or topically |
| 12/30/2004 | US20040265390 carriers for group IB compounds such as silver nitrate comprising beads made of inert polymers, ceramics or stainless steels, used for treatment of menorrhagia |
| 12/30/2004 | US20040265378 Method and compositions for producing granules containing high concentrations of biologically active substances |